The Sentinel Project’s Advocacy Task Force has developed Rapid Clinical Advice on the use of new TB drugs bedaquiline and delamanid in children.
The Rapid Clinical Advice was produced by a global committee of 18 clinicians who are experts in the management of multidrug-resistant TB (MDR-TB) in children.
The document is meant to complement the Sentinel Project’s Field Guide on the management of MDR-TB in children (available here) and synthesize timely clinical guidance on the use of new drugs for providers who are caring for children with drug-resistant TB.
Rapid Clinical Advice: The Use of Bedaquiline and Delamanid for Children with Drug-Resistant Tuberculosis is available as a PDF here.
Source: Sentinel Project